DNLI Denali Therapeutics Inc

Ownership history in MassMutual Private Wealth & Trust, FSB  ·  13 quarters on record

AI Ownership Summary

MassMutual Private Wealth & Trust, FSB reported Denali Therapeutics Inc (DNLI) in 13 quarterly 13F filings from 2023 Q4 through 2026 Q1. The latest visible filing shows DNLI at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this DNLI ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was MassMutual Private Wealth & Trust, FSB's position in Denali Therapeutics Inc, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

DNLI was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.0% in 2024 Q3

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How MassMutual Private Wealth & Trust, FSB held DNLI — position size vs. price
% of Fund (quarterly)    DNLI price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 10 quarters  
Quarter Action Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 UNCHANGED 143 0% 0.00% $3K 2026-04-13 $19.42
2025 Q4 UNCHANGED 143 0% 0.00% $2K 2026-01-07 $16.95
2025 Q3 ADDED 143 +20 +16.3% 0.00% $2K 2025-10-22 $15.95
2025 Q2 REDUCED 123 -25 -16.9% 0.00% $2K 2025-07-09 $15.00
2025 Q1 REDUCED 148 -6 -3.9% 0.00% $2K 2025-04-01 $12.29
2024 Q4 UNCHANGED 154 0% 0.00% $3K 2025-01-16 $21.67
2024 Q3 UNCHANGED 154 0% 0.00% $4K 2024-10-02 $29.03
2024 Q2 REDUCED 154 -11 -6.7% 0.00% $4K 2024-07-02 $21.74
2024 Q1 ADDED 165 +48 +41.0% 0.00% $3K 2024-04-09 $19.44
2023 Q4 ADDED 117 +84 +254.5% 0.00% $3K 2024-01-03 $20.33
3 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

FAQ About MassMutual Private Wealth & Trust, FSB and DNLI

These are the practical questions this page is built to answer before you even open the full history table.

How long has MassMutual Private Wealth & Trust, FSB reported owning DNLI?

MassMutual Private Wealth & Trust, FSB reported DNLI across 10 quarterly 13F filings, from 2023 Q4 through 2026 Q1.

What was the largest reported DNLI position in MassMutual Private Wealth & Trust, FSB's portfolio?

The largest reported portfolio weight for DNLI was 0.00% in 2024 Q3.

What is the latest reported DNLI position on this page?

The most recent filing on this page is 2026 Q1, when MassMutual Private Wealth & Trust, FSB reported 143 shares, equal to 0.00% of portfolio, with an estimated market value of $3K.

What does the chart on this DNLI ownership page compare?

The chart compares MassMutual Private Wealth & Trust, FSB's quarterly DNLI portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to MassMutual Private Wealth & Trust, FSB Holdings